Carisoprodol News
Carisoprodol 250-mg Tablets Provide Greater Relief of Acute Back Spasm Than Placebo: Presented at AAPM
Patients with acute, painful musculoskeletal spasms of the lower back appear to get better and faster relief from the muscle relaxant carisoprodol than from placebo.
Meda: FDA Approves SOMA 250mg
The Food and Drug Administration (FDA) has approved SOMA (carisoprodol) 250 mg as a new recommended dose. SOMA is a skeletal muscle relaxant, indicated for treatment of painful musculoskeletal conditions such as backache. SOMA is...
House strips muscle relaxer from drug bill
A House panel today denied an effort to place an often abused muscle relaxant on the state's controlled substance list.
Impairment due to intake of carisoprodol
Background: Carisoprodol is a centrally acting muscle relaxant commonly used for lower back pain. It is a drug of abuse and has been detected among impaired drivers. Carisoprodol's active metabolite meprobamate is thought to act...
FDA Safety Changes: Tysabri and Soma
The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise that natalizumab intravenous infusion is linked to a risk for progressive multifocal leukoencephalopathy and is therefore only available...